Skip to content

Released Jan 25, 2021, after the close

10-K filed Mar 11, 2021, 70 days after period end · 0001104659-21-034761

Q4 2020 · 10-K
Revenue$0.00— vs Q4 2019no prior Q3 2020 on file
Net Income-$4.51MderivedN/M vs Q4 2019N/M vs Q3 2020
EPS, diluted—
Operating Incomederived-$4,801,674N/M
Operating Cash Flowderived-$3,684,029N/M

What the release said

The release

Same quarter

MetricQ4 2020Q4 2019derived from reported figuresQ4 2018Q4 2017
Revenue$0.00$0.00$0.00$0.00
Net Income-$4.51M-$3.29M-$3.23M-$5.33M
EPS Diluted——-$0.15-$0.25

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR